Published in Drug Law Weekly, December 19th, 2006
This report provides a broad review of the dynamic worldwide biochip business. Biochips are becoming more diverse and customers from North America, Europe and Asia are demanding these products. The products from the biochip market are being used to help accelerate the research processes and capabilities of bio-pharmaceutical drug discovery, diagnostics and basic academic medical research.
In recent history, the big pharma companies have suffered increasing R&D costs while their actual output of new drugs has declined. Drug companies...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.